The allergic asthma therapeutics market is estimated to be valued at US$ 7.26 Bn in 2023 and is expected to exhibit a CAGR of 3.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Allergic asthma therapeutics include medicines for the treatment of asthma triggered by allergies such as drugs, immunotherapy, and other...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian